YouTube2Text

Anesthesia Emergency: Malignant Hyperthermia — Transcript

by Max Feinstein · 2,449 words · 402 segments · language en · Watch on YouTube

Full transcript

  1. 0:00i'm max feinstein and i'm an anesthesia
  2. 0:02resident at the mount sinai hospital in
  3. 0:03new york city it's been said that
  4. 0:05anesthesiology is characterized by hours
  5. 0:08of boredom punctuated by moments of
  6. 0:10terror and in this video i'm going to be
  7. 0:13discussing something that can lead to
  8. 0:14moments of terror a rare but potentially
  9. 0:17life-threatening condition called
  10. 0:19malignant hyperthermia if you find this
  11. 0:21video interesting or helpful i'd really
  12. 0:23appreciate it if you liked it and
  13. 0:24subscribe to the channel let's dive in
  14. 0:30malignant hyperthermia can be defined as
  15. 0:33a life-threatening
  16. 0:34hyper-metabolic state characterized by
  17. 0:37dysregulated calcium which as you may
  18. 0:40know plays a paramount role in muscle
  19. 0:43contraction who does malignant
  20. 0:44hyperthermia affect it affects people
  21. 0:46who are both genetically susceptible and
  22. 0:49have received exposure to a triggering
  23. 0:52agent and those include a depolarizing
  24. 0:54neuromuscular blocking drug called
  25. 0:56succinylcholine as well as several
  26. 0:59anesthetic gases including isofluorine
  27. 1:02sibo fluorine and despalurin and also
  28. 1:05halothane however halothane is not used
  29. 1:08very commonly in the united states
  30. 1:09although it is currently used in a
  31. 1:11number of other places around the world
  32. 1:13so depending on where you're practicing
  33. 1:14this might be relevant how frequent is
  34. 1:16it to be genetically susceptible to
  35. 1:18malignant hyperthermia it's more
  36. 1:20prevalent in kids with an estimated
  37. 1:22prevalence of 1 in 15 000 pediatric
  38. 1:26patients and less prevalent in adults
  39. 1:28with an estimated prevalence of 1 in 40
  40. 1:31000 patients it's really important to
  41. 1:33keep in mind that even if someone is
  42. 1:35genetically susceptible to malignant
  43. 1:36hyperthermia that does not necessarily
  44. 1:39mean that exposure to a triggering agent
  45. 1:41is going to cause an episode of
  46. 1:43malignant hyperthermia and that brings
  47. 1:45me to my next point which is how often
  48. 1:47an anesthesiologist might actually
  49. 1:49expect to see malignant hyperthermia a
  50. 1:51study that was published about 10 years
  51. 1:53ago found that there were 84 identified
  52. 1:56and reported events of malignant
  53. 1:57hypothermia that occurred over a
  54. 1:59five-year period and out of those 84
  55. 2:02events eight of those patients died that
  56. 2:04means that over the study period about
  57. 2:061.6 people died in the united states
  58. 2:10every year from an episode of malignant
  59. 2:11hyperthermia by way of comparison every
  60. 2:14year in the united states an average of
  61. 2:1662 people are killed from a lightning
  62. 2:19strike that means that on average in a
  63. 2:22given year in the united states a person
  64. 2:24is about 39 times more likely to die
  65. 2:27from a lightning strike than they are
  66. 2:29from an episode of malignant
  67. 2:30hyperthermia and the really important
  68. 2:32qualifier for that is that if an
  69. 2:34anesthesiologist is prepared
  70. 2:36then identifying and treating malignant
  71. 2:38hyperthermia can be life-saving how do
  72. 2:40you treat a patient who you think may
  73. 2:42have malignant hyperthermia well first
  74. 2:44it's important to understand what
  75. 2:46exactly is going on when an episode of
  76. 2:48malignant hyperthermia occurs if someone
  77. 2:50who's genetically susceptible is exposed
  78. 2:53to a triggering agent it may cause an
  79. 2:56uncontrolled release of calcium in cells
  80. 2:59basically throughout the body this
  81. 3:01uncontrolled calcium release occurs in
  82. 3:03muscles throughout the body causing them
  83. 3:05to contract which is a process that uses
  84. 3:08a lot of energy a lot of oxygen and
  85. 3:11produces a lot of carbon dioxide or co2
  86. 3:14there are a number of significant
  87. 3:16complications that can arise from an
  88. 3:17episode of malignant hyperthermia and
  89. 3:20one that can manifest immediately and be
  90. 3:22life-threatening is hyperkalemia which
  91. 3:25is elevated potassium levels throughout
  92. 3:27the body which can occur because
  93. 3:29potassium regulation is also thrown off
  94. 3:32during an episode of malignant
  95. 3:33hyperthermia this in and of itself can
  96. 3:35lead to a fatal cardiac arrest just as
  97. 3:38an aside for anyone thinking about a
  98. 3:40career in anesthesiology it's worth
  99. 3:42pointing out that we are experts in
  100. 3:44resuscitation including
  101. 3:46advanced cardiac life support so if
  102. 3:48there is a cardiac arrest or any other
  103. 3:51type of life-threatening event that
  104. 3:52occurs in or near an operating room then
  105. 3:55we are very well equipped to handle that
  106. 3:57other potential complications of
  107. 3:58malignant hyperthermia include a
  108. 4:00condition called disseminated
  109. 4:01intravascular coagulation which in and
  110. 4:04of itself can be fatal as well as organ
  111. 4:06failure of basically any organ
  112. 4:09especially including the brain as well
  113. 4:11as the kidneys studies show that the
  114. 4:13mortality rate associated with an
  115. 4:15episode of malignant hyperthermia ranges
  116. 4:17from 5
  117. 4:18to 30 percent
  118. 4:20where faster time to treatment is going
  119. 4:22to lead to improved survival so how do
  120. 4:25you take care of a patient who may have
  121. 4:27malignant hyperthermia and be
  122. 4:29susceptible to having an event during
  123. 4:31your anesthetic the first consideration
  124. 4:33is to make your patient the first
  125. 4:36patient of the day reason being that
  126. 4:38studies have demonstrated that overnight
  127. 4:41the triggering agents that are present
  128. 4:43inside of anesthesia machines actually
  129. 4:45degrade when the machine is not in use
  130. 4:48so you don't want to be using a
  131. 4:50triggering agent like isofluorine or
  132. 4:52sibo chlorine throughout the course of
  133. 4:53the day and then take care of a patient
  134. 4:56using that same machine which may have
  135. 4:59some lingering molecules of a triggering
  136. 5:01agent inside of it then as far as the
  137. 5:03machine itself is concerned you actually
  138. 5:05want to remove every replaceable part
  139. 5:07that could potentially have come into
  140. 5:09contact with the triggering agent that
  141. 5:11includes the entire breathing circuit
  142. 5:13the absorbent and if it's possible to
  143. 5:16remove the vaporizers from the machine
  144. 5:18then you should go ahead and take those
  145. 5:20off if it's not possible to remove the
  146. 5:22vaporizers then at the very least cover
  147. 5:25them in red tape so it's abundantly
  148. 5:27clear that they shouldn't be used
  149. 5:29then if you have charcoal filters
  150. 5:31available go ahead and place those on
  151. 5:33your circuit and flush the circuit and
  152. 5:36the anesthesia machine for a certain
  153. 5:37period of time depending on whether you
  154. 5:39have filters on and what type of
  155. 5:41anesthesia machine you're using i should
  156. 5:43point out that if you're not able to use
  157. 5:45charcoal filters then it's really
  158. 5:47important to keep your gas flows high
  159. 5:50throughout the course of the anesthetic
  160. 5:52because it's possible for triggering
  161. 5:54agents to re-accumulate if the flows
  162. 5:56aren't high enough a big challenge for
  163. 5:59anesthesiologists is that an episode of
  164. 6:01malignant hyperthermia isn't always very
  165. 6:03easy to identify but if you think that
  166. 6:06your patient may be having an episode
  167. 6:07it's extraordinarily important to
  168. 6:09initiate treatment as early as possible
  169. 6:12due to the muscle contractions that
  170. 6:13happen throughout the body during an
  171. 6:15episode of malignant hyperthermia one of
  172. 6:17the signs that may tip you off that your
  173. 6:20patients having an episode is muscle
  174. 6:22rigidity throughout the body and
  175. 6:23especially in the masseter muscles of
  176. 6:25the face keep in mind that muscle
  177. 6:27rigidity doesn't always happen during
  178. 6:29malignant hyperthermia and also keep in
  179. 6:31mind that other conditions like
  180. 6:32neuroleptic malignant syndrome can also
  181. 6:34cause muscle rigidity so this in and of
  182. 6:37itself isn't going to be the single
  183. 6:38diagnostic indicator that a patient's
  184. 6:41actually having an episode another
  185. 6:42really important sign that your patient
  186. 6:44may be having an episode of malignant
  187. 6:46hyperthermia is hypercarbia which means
  188. 6:49increased levels of co2 monitoring a
  189. 6:51patient's exhaled co2 is one of the
  190. 6:54american society of anesthesiologists
  191. 6:56standards of care so we're always
  192. 6:58watching a patient's end tidal co2 which
  193. 7:00means what they're breathing off and so
  194. 7:03if that in tidal co2 is rising and
  195. 7:05especially if a patient is intubated and
  196. 7:08we try to breathe off that co2 by either
  197. 7:11increasing the respiratory rate and or
  198. 7:13increasing the tidal volumes but the co2
  199. 7:16is not going down then we have another
  200. 7:18indicator that the patient may be having
  201. 7:20an episode of malignant hyperthermia
  202. 7:22other less specific signs of malignant
  203. 7:24hyperthermia meaning ones that can be
  204. 7:27present in a number of different
  205. 7:28conditions include tachycardia or an
  206. 7:31increased heart rate as well as an
  207. 7:33increased temperature hence the name
  208. 7:34malignant hyperthermia keep in mind that
  209. 7:37monitoring temperature is part of the
  210. 7:39american society for anesthesiologists
  211. 7:41standards for basic anesthetic
  212. 7:43monitoring overall making an
  213. 7:45intraoperative diagnosis of malignant
  214. 7:46hyperthermia can be pretty hard to do
  215. 7:49but you have a higher likelihood of
  216. 7:50making correct diagnosis that there are
  217. 7:52at least two signs that are present as
  218. 7:54far as timing goes the majority of
  219. 7:56episodes of malignant hyperthermia occur
  220. 7:59in the operating room during the
  221. 8:00delivery of anesthesia and only a small
  222. 8:03proportion of them occur after
  223. 8:04anesthesia has finished in the
  224. 8:06post-anesthesia care unit if you're
  225. 8:08delivering anesthesia and you suspect
  226. 8:11that a patient is undergoing an episode
  227. 8:13of malignant hyperthermia then the very
  228. 8:15first thing that you need to do is
  229. 8:17discontinue whatever triggering agents
  230. 8:19are currently being administered that
  231. 8:21might include isofluorine or sibo
  232. 8:23fluorine it's pretty unlikely that you
  233. 8:25have a succimal choline infusion going
  234. 8:27but if you do then you should stop that
  235. 8:29if the surgery needs to continue but
  236. 8:31you've just turned off an inhaled
  237. 8:33anesthetic maintenance agent then you'll
  238. 8:35need to switch over to a total iv
  239. 8:37anesthesia or tiva for short this
  240. 8:39commonly includes propofol which is not
  241. 8:42a triggering agent for malignant
  242. 8:43hyperthermia the next extremely time
  243. 8:46sensitive intervention that needs to
  244. 8:47occur is the administration of the
  245. 8:50treatment which is dandruline dandruline
  246. 8:52is a medication that blocks calcium
  247. 8:55release from muscles and thereby
  248. 8:57inhibits the pathophysiology of what's
  249. 9:00going on during an episode of malignant
  250. 9:01hyperthermia a patient's survival of an
  251. 9:04episode of malignant hyperthermia is
  252. 9:06directly related to the amount of time
  253. 9:08that it takes for dandruline to be
  254. 9:10administered for those who are
  255. 9:11interested the dose of dandruline is 2.5
  256. 9:14milligrams per kilogram administered
  257. 9:17every 5 minutes and it's important to
  258. 9:19monitor a patient's vital signs for
  259. 9:21resolution of symptoms
  260. 9:22and also keep in mind that treatment
  261. 9:24with dandruline may need to continue
  262. 9:26even after symptoms have resolved
  263. 9:28because it's possible for them to
  264. 9:29reoccur dandruline is an extremely
  265. 9:32expensive medication and for that reason
  266. 9:34it's not routinely kept in carts in
  267. 9:37every single operating room but rather
  268. 9:39in its own cart that's located centrally
  269. 9:41to all of the operating rooms
  270. 9:43i've covered medication cost in one of
  271. 9:45my previous videos and i will say that
  272. 9:48that became a very controversial subject
  273. 9:50but i will just say that objectively
  274. 9:52speaking the wholesale cost so what a
  275. 9:55hospital pays in the united states on
  276. 9:57average for a vial of dantrolene is 2581
  277. 10:04for 250 milligrams that's the cost for a
  278. 10:08formulation of dandruline that can be
  279. 10:10reconstituted into five cc's of sterile
  280. 10:13water and then injected that contrasts
  281. 10:15with the other formulation of
  282. 10:17intravenous dandruline which comes as 20
  283. 10:20milligram files that cost 62 each but
  284. 10:24each vial needs to be mixed with 60 ccs
  285. 10:27of sterile water from a practical
  286. 10:29standpoint this formulation of
  287. 10:31dandruline is actually really tedious to
  288. 10:33use because it takes a long time to draw
  289. 10:37up enough dandruline to administer to a
  290. 10:39patient who's having an episode of
  291. 10:40malignant hyperthermia one also cannot
  292. 10:43talk about dandruline without mentioning
  293. 10:45that calcium channel blockers are
  294. 10:47contraindicated because the use of
  295. 10:49calcium channel blockers with dandruline
  296. 10:51can precipitate a life-threatening
  297. 10:53hyperkalemic arrest
  298. 10:55also kept in the cart is refrigerated iv
  299. 10:57fluid and in this case that's isolite
  300. 11:00the administration of cold iv fluids is
  301. 11:03one of the most effective ways to
  302. 11:04rapidly cool a patient
  303. 11:06another medication kept in the malignant
  304. 11:08hyperthermia cart is a medication called
  305. 11:10bicarbonate which can decrease the
  306. 11:12acidity of urine thereby decreasing the
  307. 11:16likelihood of kidney damage resulting
  308. 11:18from myoglobin which came from ruptured
  309. 11:21muscle cells to that end a diuretic
  310. 11:24called furosemide is also recommended
  311. 11:26for treatment during a malignant
  312. 11:27hyperthermia episode because that can
  313. 11:29increase urine output and theoretically
  314. 11:31decrease the amount of renal damage the
  315. 11:34malignant hyperthermia cart also
  316. 11:35includes insulin which drives potassium
  317. 11:38inside of cells decreasing the
  318. 11:40likelihood of life-threatening
  319. 11:42hyperkalemia and if you're going to be
  320. 11:44administering insulin then in order to
  321. 11:46keep the patient's blood sugar from
  322. 11:48bottoming out you'll also probably need
  323. 11:50to administer dextrose which is kept in
  324. 11:52the cart as well the recommended
  325. 11:53ventilator settings for treating a
  326. 11:55patient with a suspected episode of
  327. 11:57malignant hyperthermia is a hundred
  328. 11:59percent fio2 at high flows and
  329. 12:02hyperventilating the patient to try to
  330. 12:04get the carbon dioxide off as much as
  331. 12:06possible other important steps for
  332. 12:08treating malignant hyperthermia include
  333. 12:10making sure that a patient's urine is
  334. 12:12being closely monitored so a foley
  335. 12:14catheter will need to be inserted if
  336. 12:16it's not already inserted and the
  337. 12:18patient will need to be very closely
  338. 12:19monitored in the icu after leaving the
  339. 12:22operating room and if there's any
  340. 12:24question about how to treat a patient
  341. 12:26with a suspected episode of malignant
  342. 12:27hyperthermia there's actually a hotline
  343. 12:29that's staffed 24 7 by experts who can
  344. 12:32guide you through any questions that you
  345. 12:34may have
  346. 12:35there are several ways that
  347. 12:37susceptibility to malignant hyperthermia
  348. 12:39can be diagnosed one is a fairly
  349. 12:41invasive diagnostic test that is not
  350. 12:44done in very many places in the united
  351. 12:46states and also happens to be really
  352. 12:48expensive and that's called a caffeine
  353. 12:50halothane contracture test that
  354. 12:52basically entails taking a fairly
  355. 12:54sizable amount of a muscle sample and
  356. 12:57then exposing it to both halothane which
  357. 12:59is an anesthetic agent as well as
  358. 13:01caffeine and seeing if the muscle
  359. 13:03contracts because this test is so
  360. 13:05invasive
  361. 13:06and expensive and inconvenient it's not
  362. 13:09routinely done except in people who have
  363. 13:12a high suspicion of having had an
  364. 13:13episode of malignant hyperthermia and
  365. 13:16even in that case this test can't be
  366. 13:18done within six months of a suspected
  367. 13:20episode of millennium hypothermia
  368. 13:22because it can throw off the test
  369. 13:23results another way of identifying
  370. 13:26people who are susceptible to malignant
  371. 13:27hyperthermia is a blood test that can
  372. 13:30identify certain genes that predispose
  373. 13:32someone to it however these are not
  374. 13:34particularly sensitive genetic tests
  375. 13:36which means they don't always pick up
  376. 13:38when somebody has susceptibility to
  377. 13:40malignant hyperthermia that's because
  378. 13:42there are a lot of different genetic
  379. 13:43mutations that can lead to malignant
  380. 13:45hyperthermia and we don't know what all
  381. 13:47of those genetic markers are so we can't
  382. 13:50test for all of them so if a patient's
  383. 13:52had a negative blood test that's not
  384. 13:54necessarily helpful but if a patient has
  385. 13:56a positive blood test then that can be
  386. 13:58something that can be helpful in
  387. 14:00allowing other family members who are
  388. 14:02genetically related to get identified as
  389. 14:05carriers of a genetic mutation that can
  390. 14:07lead to susceptibility for malignant
  391. 14:09hyperthermia if you do have questions or
  392. 14:12concerns about malignant hyperthermia
  393. 14:13the person that you need to speak with
  394. 14:15is your doctor because this is a youtube
  395. 14:18video and this is not medical advice if
  396. 14:20you found this video interesting you
  397. 14:21might want to check out this video where
  398. 14:23i go through a totally different type of
  399. 14:25emergency that i actually did experience
  400. 14:28in an operating room thanks very much
  401. 14:30for watching i'll see you next time
  402. 14:37[Music]

About this transcript

This page contains the full transcript of Anesthesia Emergency: Malignant Hyperthermia by Max Feinstein, generated from the public captions YouTube serves with the video. The transcript has 2,449 words across 402 segments, with the original timestamps preserved so you can click any line to jump to that moment in the embedded player.

What you can do with it

Use the transcript to take notes, quote the speaker, build a study guide, generate a summary with ChatGPT or Claude via the YouTube Summary tool, or export it as a timed subtitle file with YouTube to SRT. You can also re-open it in the transcriber to translate the transcript into 100+ languages.

Free YouTube transcript tool

YouTube2Text is a free YouTube transcript generator — no signup, no daily limit. Paste any YouTube link and get the full transcript instantly, with timestamps, click-to-jump, translation to 100+ languages, AI prompts for ChatGPT, Claude, and Gemini, and exports to TXT, SRT, VTT, or Markdown.